Works matching IS 13570560 AND DT 2015 AND VI 32 AND IP 10

Results: 9

Safety and efficacy of combination therapy with low-dose gemcitabine, paclitaxel, and sorafenib in patients with cisplatin-resistant urothelial cancer.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0683-y

By:

Miyata, Yasuyoshi;
Asai, Akihiro;
Mitsunari, Kensuke;
Matsuo, Tomohiro;
Ohba, Kojiro;
Sakai, Hideki

Publication type:

Article

Retraction Note to: Decreased Warburg effect induced by ATP citrate lyase suppression inhibits tumor growth in pancreatic cancer.

Published in:

2015

By:

Zong, Haifeng;
Zhang, Yang;
You, Yong;
Cai, Tiantian;
Wang, Yehuang

Publication type:

Erratum

TRAF6 is required for BLyS-mediated NF-κB signaling in multiple myeloma cells.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0671-2

By:

Wang, Xinfeng;
Wang, Jingjing;
Liu, Hong;
Xu, Ruirong;
Ding, Runsheng;
Jiang, Shenhua;
Wang, Xudong;
Huang, Hongming

Publication type:

Article

A prospective randomized clinical trial comparing D2 dissection in laparoscopic and open gastrectomy for gastric cancer.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0680-1

By:

Cui, Ming;
Li, Ziyu;
Xing, Jiadi;
Yao, Zhendan;
Liu, Maoxing;
Chen, Lei;
Zhang, Chenghai;
Yang, Hong;
Zhang, Nan;
Tan, Fei;
Jiang, Beihai;
Di, Jiabo;
Wang, Zaozao;
Ji, Jiafu;
Su, Xiangqian

Publication type:

Article

Is the exhaled breath temperature in lung cancer influenced by airways neoangiogenesis or by inflammation?

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0681-0

By:

Carpagnano, Giovanna;
Lacedonia, Donato;
Spanevello, Antonio;
Cotugno, Grazia;
Saliani, Valerio;
Martinelli, Domenico;
Foschino-Barbaro, Maria

Publication type:

Article

Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0682-z

By:

Freyer, Gilles;
Kalinka-Warzocha, Ewa;
Syrigos, Konstantinos;
Marinca, Mihai;
Tonini, Giuseppe;
Ng, Say;
Wong, Zee;
Salar, Antonio;
Steger, Guenther;
Abdelsalam, Mahmoud;
DeCosta, Lucy;
Szabo, Zsolt

Publication type:

Article

Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0684-x

By:

Li, Jianhua;
Qiu, Xinguang;
Guo, Wenzhi;
Yan, Bing;
Zhang, Shuijun

Publication type:

Article

Efficacy and safety of pirarubicin plus capecitabine versus pirarubicin plus cyclophosphamide in Chinese node-negative breast cancer patients: a 4-year open-label, randomized, controlled study.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0686-8

By:

Zhang, Xiaohui;
Zhou, Yidong;
Mao, Feng;
Lin, Yan;
Guan, Jinghong;
Sun, Qiang

Publication type:

Article

Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial.

Published in:

Medical Oncology, 2015, v. 32, n. 10, p. 1, doi. 10.1007/s12032-015-0687-7

By:

Ochenduszko, Sebastian;
Puskulluoglu, Miroslawa;
Konopka, Kamil;
Fijorek, Kamil;
Urbanczyk, Katarzyna;
Budzynski, Andrzej;
Matlok, Maciej;
Lazar, Agata;
Sinczak-Kuta, Anna;
Pedziwiatr, Michal;
Krzemieniecki, Krzysztof

Publication type:

Article